Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A288904
Thu, 19.06.2025
CompuGroup Medical SE & Co. KGaA
Frankfurt Stock Exchange confirms delisting to take effect at the end of the acceptance period for the public delisting offer by CVC Capital Partners
CGM shareholders can still tender shares until 24 June 2025 at 24:00 CEST
Delisting offer is not subject to any closing conditions and delisting will take effect regardless of the amount of share [ … ]
Fri, 06.06.2025
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer
Offer price of EUR 22.00 per share is considered fair and reasonable; Managing Directors, Administrative Board and Supervisory Board each recommend accepting the offer
Acceptance period ends 24 June 2025 at 24:00 CEST
CGM will b [ … ]
Thu, 08.05.2025
CompuGroup Medical SE & Co. KGaA
CVC to launch public delisting offer of EUR 22.00 in cash per share as planned
Managing Directors, Supervisory Board and Administrative Board of CompuGroup Medical welcome public delisting offer
Offer provides CGM shareholders with the opportunity to sell their shares independently of market liquidity prior to delisting
Delisting will enable Com [ … ]
Thu, 08.05.2025
Caesar BidCo GmbH
EQS-WpÜG: Caesar BidCo GmbH / Tender Offer
Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH
08.05.2025 / 22:05 CET/CEST
Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQS News - a service of EQS Group.
The bidder is sole [ … ]
Wed, 30.04.2025
CompuGroup Medical SE & Co. KGaA
Q1/2025: CompuGroup Medical reports slow start into the year
Koblenz - CompuGroup Medical, one of the world's leading e-health providers, recorded revenues of EUR 286.2 million in the first quarter of 2025, 1 percent higher than the previous year's level (PY: EUR 284.6 million). The organic revenue development was slightly below the prior year (- [ … ]
Thu, 17.04.2025
CompuGroup Medical SE & Co. KGaA
All offer conditions fulfilled through regulatory approvals
Upon completion of the offer, CVC secures a minority stake of 23.11%[1] in
CompuGroup Medical, shareholder around founding family Gotthardt retain majority stake with 50.12%
Delisting offer planned shortly – no increase over tender offer price expected
Koblenz, Frankfurt - Caesar BidCo [ … ]
Thu, 06.03.2025
CompuGroup Medical SE & Co. KGaA
Koblenz - CompuGroup Medical, one of the world's leading e-health providers, recorded revenues of EUR 1,154.0 million in the 2024 financial year, 3 percent below the previous year's level (PY: EUR 1,187.7 million), which was attributable to high one-off effects in the previous year. Organically, revenues were 2 percent below the prior year. At EUR [ … ]
Tue, 04.03.2025
CompuGroup Medical SE & Co. KGaA
The general partner and the supervisory board of CompuGroup Medical SE & Co. KGaA (the „Company“) (ISIN: DE000A288904 | WKN: A28890) intend to propose to the annual general meeting that only the legally required minimum shall be paid out as dividend for the financial year 2024. This would result in a distribution of EUR 0.05 per dividend bearin [ … ]
Fri, 14.02.2025
CompuGroup Medical SE & Co. KGaA
Closing of the transaction is expected in the second quarter of 2025, subject to regulatory approvals
Delisting offer planned shortly after successful completion of the transaction – no increase over the current tender offer price expected
CVC has secured a minority stake of 21.85% in CompuGroup Medical while founding family Gotthardt retains maj [ … ]
Tue, 28.01.2025
CompuGroup Medical SE & Co. KGaA
Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 January to 11 February 2025
Tender offer successful (subject to regulatory approvals): At the end of the acceptance period, CVC holds 20.43% of total share capital and voting rights in CompuGroup Medical
Additional accept [ … ]